Khiron Life Sciences Corp. has entered into a partnership with an accredited 3rd Party contract manufacturing organization (CMO) in Colombia to outsource the production of Khiron-branded medical cannabis products. Under this agreement, Khiron's partner has: i) purchased Khiron's extraction and laboratory equipment, ii) stored the Company's existing inventory of dried flower and full spectrum extracts to manufacture final product for the Company.

In addition, Khiron's partner will distribute products to Khiron and Zerenia's patients across Colombia. Through this partnership, Khiron will also be able to leverage the partner's established network of over 300 hospitals and pharmacies across Colombia to increase product sales. Moving forward, Khiron will continue to implement initiatives to simplify the Company's overall group structure in Latin America, focusing on business operations with a clear short-term positive cashflow outlook.